10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics of single and multiple doses of
10mg ZD4054 (Zibotentan) in male, elderly Chinese patients with advanced solid malignancies.